US-China tensions offer new opportunity for APAC biotechs, report suggests

Investors are increasingly focused on biotech companies outside of China operating in the Asia-Pacific (APAC) market, according to a report by management consulting firm Bain & Company. Homing in on Singapore specifically, the report states that rising players within the APAC region are drawing in…
|
||||
|
||||
You Might LikeRelated videos from verified sources
|